OX40 signaling further enhanced the function and migration of activated CD4+ and CD8+ T cells in the presence of tumor antigens, leading to low-level antigen cross-recognition and inflammation in normal tissues such as intestine, skin and liver (144–147). The gene discussed is CD4; the disease is neoplasm.